Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesDividends payablesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

National Healthcare (NHC) Common Equity (2016 - 2025)

National Healthcare (NHC) has disclosed Common Equity for 16 consecutive years, with $1.1 billion as the latest value for Q4 2025.

  • For the quarter ending Q4 2025, Common Equity rose 9.29% year-over-year to $1.1 billion, compared with a TTM value of $1.1 billion through Dec 2025, up 9.29%, and an annual FY2025 reading of $1.1 billion, up 9.29% over the prior year.
  • Common Equity was $1.1 billion for Q4 2025 at National Healthcare, up from $1.1 billion in the prior quarter.
  • Across five years, Common Equity topped out at $1.1 billion in Q4 2025 and bottomed at $810.2 million in Q1 2021.
  • Average Common Equity over 5 years is $934.0 million, with a median of $910.8 million recorded in 2022.
  • The sharpest move saw Common Equity grew 18.71% in 2021, then dropped 3.42% in 2023.
  • Year by year, Common Equity stood at $908.5 million in 2021, then fell by 3.41% to $877.5 million in 2022, then rose by 3.76% to $910.5 million in 2023, then increased by 7.98% to $983.2 million in 2024, then rose by 9.29% to $1.1 billion in 2025.
  • Business Quant data shows Common Equity for NHC at $1.1 billion in Q4 2025, $1.1 billion in Q3 2025, and $1.0 billion in Q2 2025.